glycopeptide,neutral_mass,mass_accuracy,ms1_score,ms2_score,q_value,total_signal,start_time,end_time,apex_time,charge_states,msms_count,peptide_start,peptide_end,protein_name,mass_shifts
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4442.097189645668,-2.858038319659347e-06,10.1752791654,26.8346783704,0,29391834.5,83.7255184438,83.8510663416,83.788561640803,3,1,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4290.915213387115,-8.600648679887461e-06,8.66743146472,48.1889660619,0,15739513.0,77.5138138241,77.7031736599,77.640603040282,3,2,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,Unmodified
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:3; Hex:5; HexNAc:4},4291.91950162,-4.84440479895e-06,0,47.5700998342,0,0,,,,3,1,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:1; Hex:5; HexNAc:4},3999.7975801,-3.67215415696e-06,0,45.9921411498,0,0,,,,3,1,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:2; Hex:6; HexNAc:4},4307.936186818988,-9.879992024755505e-06,5.67879731166,44.1276691622,0,23183202.25,77.5138138241,77.7504867937,77.561169257387,3,1,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,Unmodified
LN(N-Glycosylation)YSLPTGQWVGVQLPR{Hex:5; HexNAc:2},3143.4671012910267,-4.026684167072718e-06,13.6056608287,114.400118563,0,121103739.5,83.8200276401,84.1045788751,83.946366841221,3,2,1016,1033,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)NTRGPGLKR{Fuc:1; Hex:5; HexNAc:5},3083.3537211834337,-4.47380773710483e-06,16.208787602,62.9214522746,0,567834247.5,32.6429482089,32.9508930749,32.791001326466,3;4,4,787,797,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)NTRGPGLKR{Fuc:1; Hex:6; HexNAc:5},3245.4068935466053,-4.3579362678510764e-06,10.5719509419,60.4080617175,0,218538150.5,32.3477640416,32.8353998091,32.731814923509,3;4,1,787,797,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)NTRGPGLK{Fuc:5; Hex:8; HexNAc:8},4606.86273583,9.3404306715e-07,0,12.9496797752,0,0,,,,3,1,787,796,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0467326980283,-3.0887405101350763e-06,17.374569554,109.811528239,0,1717231021.5,27.023385877,27.8886629568,27.195325591787,2;3,4,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:6; HexNAc:2},2487.0822105675907,-7.580156269233379e-06,17.2925231271,77.9463236814,0,327254244.25,52.2554050233,52.7135028428,52.424914040788,2,1,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
LKISYKDAIN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},3873.6916045052803,-6.6469282507759885e-06,11.5655139828,40.3608366351,0,155763171.25,49.2083355413,49.4936218089,49.343756241226,3;4,2,2780,2791,sp|P15924|DESP_HUMAN Desmoplakin OS=Homo sapiens OX=9606 GN=DSP PE=1 SV=3,Unmodified
VVLHPN(N-Glycosylation)YSQVDIGLIK{Hex:5; HexNAc:4; Neu5Ac:2},3998.79067059969,-3.5662622165267882e-06,-21.5205971189,10.0373077825,0.0118343195266,1812772.75,74.4523837592,74.4523837592,74.452383759244,3,1,235,251,sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1,Unmodified
TVIRPFYLTN(N-Glycosylation)SSGVD{Hex:8; HexNAc:2},3370.42956616,1.08352365431e-06,0,19.1494345365,0,0,,,,3,1,570,585,sp|Q08380|LG3BP_HUMAN Galectin-3-binding protein OS=Homo sapiens OX=9606 GN=LGALS3BP PE=1 SV=1,
GLN(N-Glycosylation)LTEDTYKPR{Fuc:2; Hex:8; HexNAc:4; Neu5Ac:1},4097.65759765,3.38172423123e-06,0,12.1391205791,0.00662251655629,0,,,,3,1,395,407,sp|Q08380|LG3BP_HUMAN Galectin-3-binding protein OS=Homo sapiens OX=9606 GN=LGALS3BP PE=1 SV=1,
AEPPLN(N-Glycosylation)ASASDQGEK{Hex:5; HexNAc:2},2729.14279310519,-5.245446206131723e-06,11.3696849928,34.8134321833,0,101960520.0,31.167346492,31.6039091931,31.283848041916,2;3,2,925,940,sp|Q9Y4L1|HYOU1_HUMAN Hypoxia up-regulated protein 1 OS=Homo sapiens OX=9606 GN=HYOU1 PE=1 SV=1,Unmodified
ALPQPQN(N-Glycosylation)VTSLLGC(Carbamidomethyl)TH{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3940.68211261,-4.30564234962e-06,0,20.7410660467,0,0,,,,3,2,446,462,sp|P02790|HEMO_HUMAN Hemopexin OS=Homo sapiens OX=9606 GN=HPX PE=1 SV=2,
FEDGVLDPDYPRN(N-Glycosylation)ISDGFDGIPDNVDAALALPAHSYSGR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},6380.745087574643,-2.218144250627972e-07,-5.67191543329,14.1542615521,0,24568792.0,94.7494270271,94.861269576,94.813189024353,4,2,229,268,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,Unmodified
EEQFN(N-Glycosylation)STFR{Fuc:1; Hex:3; HexNAc:4},2601.0661081176218,-6.6655194835573295e-06,17.476045884,93.3713769122,0,1279721072.625,39.5690525598,40.2408429927,39.869825508817,2;3,4,171,180,sp|P01859|IGHG2_HUMAN Immunoglobulin heavy constant gamma 2 OS=Homo sapiens OX=9606 GN=IGHG2 PE=1 SV=3,Unmodified
RN(N-Glycosylation)GTLPWLRPDSK{Hex:6; HexNAc:3},3120.39973927,-4.14107047175e-06,0,8.98471854299,0.0118343195266,0,,,,3,1,168,181,sp|P31153|METK2_HUMAN S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,
GHVN(N-Glycosylation)ITR{Hex:5; HexNAc:4; Neu5Ac:2},3000.216600138561,-3.0080725139616757e-06,15.445170314,53.2161174478,0,837385156.5,27.4703742769,28.1373017576,27.644118526204,3,1,117,124,sp|P00734|THRB_HUMAN Prothrombin OS=Homo sapiens OX=9606 GN=F2 PE=1 SV=2,Unmodified
FLSSSPHLPPSSYFN(N-Glycosylation)ASGR{Hex:3; HexNAc:2},2942.3237518487663,-5.335156305131261e-06,11.2467103976,48.5620842771,0,305474184.0,61.8238651103,62.9661298738,62.285473325475,3,1,428,447,sp|O14773|TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens OX=9606 GN=TPP1 PE=1 SV=2,Unmodified
VQKQQVFEKELAVN(N-Glycosylation)K{Hex:5; HexNAc:4; Neu5Ac:1},3700.7033372565056,-8.695727309888723e-06,11.4575532261,9.59819438619,0.00662251655629,44326870.75,60.8595270262,61.2210058596,61.063360626125,3,2,619,634,"sp|P02549|SPTA1_HUMAN Spectrin alpha chain, erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTA1 PE=1 SV=5",Unmodified
N(N-Glycosylation)ITRIK{Hex:6; HexNAc:3},2325.033124608086,-5.459687138134686e-06,12.8868254543,35.1688718215,0,130413418.625,52.5606498903,52.9899069574,52.821520291392,2,1,150,156,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:5},2929.2805321485002,-4.146932151840614e-06,12.0465177423,58.9867384273,0,99927541.0,38.0883543756,38.2801970428,38.162219507122,3,2,199,208,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:4; HexNAc:5},2767.232529308676,-6.131796340378017e-06,11.8551862869,49.3163934222,0,181937958.875,38.2801970428,38.682006926,38.355628806972,2;3,2,199,208,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3220.388939892421,-7.806127005361124e-06,14.9950201174,43.9590107218,0,318786280.75,40.8822136071,41.4539537257,41.124575625483,3,2,199,208,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
RQQYNALLSN(N-Glycosylation)MSR{Fuc:4; Hex:7; HexNAc:7; Neu5Ac:2},5302.14909727,-2.32903193852e-06,0,9.69730503593,0.0118343195266,0,,,,5,1,136,149,sp|P12821|ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens OX=9606 GN=ACE PE=1 SV=1,
LALAIFVIC(Carbamidomethyl)QLGN(N-Glycosylation)FSIHM(Oxidation)ALR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:2},5118.30264697,-8.48675581877e-06,0,18.0762448938,0,0,,,,4,1,195,216,sp|Q9NZ01|TECR_HUMAN Very-long-chain enoyl-CoA reductase OS=Homo sapiens OX=9606 GN=TECR PE=1 SV=1,
TAIFAFN(N-Glycosylation)ISHVSNK{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3445.5218759631525,-8.747565320233303e-06,-20.9079672241,11.1160929311,0.00662251655629,3040236,80.6990229235,80.6990229235,80.699022923533,3,2,2760,2774,sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},4734.081326765148,-2.968098121928893e-07,-21.3544787485,33.2704812818,0,13568496.5,83.2212748077,83.2843893753,83.284389375273,4,1,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4441.995985589682,-7.177301444382832e-06,17.6897995993,30.1829723165,0,1070684164.0,79.2151222931,79.6569384402,79.436344324176,3;4,2,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4733.080782181375,-4.4921332223451746e-06,7.57553366125,24.5208492021,0,58567715.0,83.2058757093,83.4723845746,83.205875709279,3;4,1,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},4279.943331582696,-7.488640207275347e-06,7.8418254609,20.2653880899,0,49221231.0,79.6728055901,79.846672927,79.767393810177,3,2,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:1; Hex:4; HexNAc:4},3988.837486534056,-5.420730631415333e-06,11.0436179405,17.8063300107,0,21834232.5,76.6629174417,76.7411374436,76.725274942938,3,1,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
LNYEHDN(N-Glycosylation)ISLKR{Fuc:1; Hex:4; HexNAc:4},3107.3668349357195,-3.7497802217118814e-06,12.5857464434,11.690113263,0,82486043.25,42.0973155405,42.3223833269,42.172647109254,3,2,417,429,sp|Q969X6|UTP4_HUMAN U3 small nucleolar RNA-associated protein 4 homolog OS=Homo sapiens OX=9606 GN=UTP4 PE=1 SV=1,Unmodified
IFLKEVN(N-Glycosylation)DTLLVNELK{Fuc:1; Hex:5; HexNAc:4},3655.739338695753,-7.688688084318517e-06,11.4328325449,28.4425026036,0,42837693.75,77.0267588403,77.1998927103,77.105881840611,3,2,592,608,sp|Q15063|POSTN_HUMAN Periostin OS=Homo sapiens OX=9606 GN=POSTN PE=1 SV=2,Unmodified
IFLKEVN(N-Glycosylation)DTLLVNELK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3946.8271658262665,-5.198723601234196e-06,10.7101103564,25.9823212756,0,67540661.25,80.5572299586,80.7767853604,80.667843690141,3,2,592,608,sp|Q15063|POSTN_HUMAN Periostin OS=Homo sapiens OX=9606 GN=POSTN PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0467326980283,-3.0887405101350763e-06,17.374569554,109.811528239,0,1717231021.5,27.023385877,27.8886629568,27.195325591787,2;3,4,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:5; HexNAc:2},2947.4019816294694,-6.467809701016714e-06,14.1962590909,106.208565433,0,102834667.5,81.8319413767,82.0698963072,81.943312560145,3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:5; HexNAc:2},2963.40068220096,-7.710333184857807e-06,11.9177051217,31.5723217294,0,51195915.75,74.0887458748,74.2789041744,74.199585058912,3,3,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:4; HexNAc:5},3394.585242229303,-5.016723315963299e-06,-4.05822257829,20.298590056,0,18844205.5,81.4850230919,81.5949547237,81.563387058798,3,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:4; HexNAc:5},3410.59586956,-9.60008941897e-06,0,19.6494743011,0,0,,,,3,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,
LQLSNGN(N-Glycosylation)MTLTLLSVKR{Hex:4; HexNAc:5},3550.69761865,-7.96888238855e-06,0,11.8859316656,0.00662251655629,0,,,,3,1,190,207,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:5; HexNAc:4},3369.5701171,-9.95339617962e-06,0,9.32467159783,0.0118343195266,0,,,,3,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,
RVN(N-Glycosylation)TTQKR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3426.432272626034,2.3001560891935833e-06,11.3570024052,79.8965560549,0,202063205.25,80.8392862267,81.4377881076,81.09148782355,3,2,113,121,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,Unmodified
RVN(N-Glycosylation)TTQKR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:2},3718.53602521,-0.000269045328954,0,23.4961293536,0,0,,,,3,1,113,121,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,
RVN(N-Glycosylation)TTQKR{Fuc:2; Hex:6; HexNAc:5},3281.3853295,5.27726741312e-06,0,12.2552341099,0,0,,,,3,1,113,121,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,
LHINHNN(N-Glycosylation)LTESVGPLPK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3941.773449362682,-8.225218597356179e-06,11.6631031457,18.7005499849,0,75551167.5,52.36243526,52.5159091419,52.424914040788,3;4,1,120,137,sp|P51884|LUM_HUMAN Lumican OS=Homo sapiens OX=9606 GN=LUM PE=1 SV=2,Unmodified
LHINHNN(N-Glycosylation)LTESVGPLPK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4232.864131481116,-6.541093544646038e-06,10.5240691909,16.7194693363,0,51177373.25,55.5143591271,55.6551842755,55.593334224447,3;4,1,120,137,sp|P51884|LUM_HUMAN Lumican OS=Homo sapiens OX=9606 GN=LUM PE=1 SV=2,Unmodified
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:2; Hex:6; HexNAc:4},3653.5965631593303,-4.926968486919985e-06,5.34694230127,51.381769663,0,53740345,84.3865766074,84.6370728757,84.38657660745,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3636.5673767707076,-1.135817668080627e-06,-6.58703733948,28.7879171868,0,16327809.25,84.4487770742,84.7160582568,84.448777074242,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:1; Hex:5; HexNAc:4},3345.4933161070853,-7.618105289031148e-06,9.5716643,26.3636874592,0,71604356.75,79.5308655765,79.8151629752,79.656938440228,3,2,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
LLQVVYLHSNN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3991.7691837922966,-3.468067866612529e-06,13.4996575415,15.526028478,0,230537152.5,64.722125358,65.1745411104,65.033980042362,3,2,300,314,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
LLQVVYLHSNN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4},3409.581046690204,-4.850929500722924e-06,-4.78749211795,13.5136904575,0,12941901.25,57.9958209421,58.0876953429,58.041696193441,3,2,300,314,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
KKEDALN(N-Glycosylation)ETR{Fuc:2; Hex:8; HexNAc:5; Neu5Ac:1},4097.67696619,-5.06812359848e-06,0,17.7582091672,0,0,,,,3,1,79,89,sp|P10909|CLUS_HUMAN Clusterin OS=Homo sapiens OX=9606 GN=CLU PE=1 SV=1,
LHFRN(N-Glycosylation)ISR{Fuc:1; Hex:6; HexNAc:7; Neu5Ac:1},3875.58137503,-0.000766931458039,0,10.1012577116,0.0208333333333,0,,,,3,1,379,387,sp|Q96HE7|ERO1A_HUMAN ERO1-like protein alpha OS=Homo sapiens OX=9606 GN=ERO1A PE=1 SV=2,
QVVEN(N-Glycosylation)MTR{Hex:3; HexNAc:2},1867.8072914769173,-4.985114561854876e-06,17.0989593377,139.597444676,0,524857597.25,29.7226187414,30.0750408596,29.826964643224,2,2,385,393,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
GVFITN(N-Glycosylation)ETGQPLIGK{Hex:6; HexNAc:2},2951.345457280812,-6.307053586702598e-06,14.9298689748,122.513830206,0,175507555.375,62.7638987408,63.0123914904,62.904489857578,2;3,1,464,479,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
GVFITN(N-Glycosylation)ETGQPLIGK{Hex:5; HexNAc:2},2789.2918590833756,-6.395714725037431e-06,13.4821270614,119.405833698,0,142703027.25,63.0428292936,63.3068048106,63.181379376475,2;3,5,464,479,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:5},2929.2805321485002,-4.146932151840614e-06,12.0465177423,58.9867384273,0,99927541.0,38.0883543756,38.2801970428,38.162219507122,3,2,314,323,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:4; HexNAc:5},2767.232529308676,-6.131796340378017e-06,11.8551862869,49.3163934222,0,181937958.875,38.2801970428,38.682006926,38.355628806972,2;3,2,314,323,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3220.388939892421,-7.806127005361124e-06,14.9950201174,43.9590107218,0,318786280.75,40.8822136071,41.4539537257,41.124575625483,3,2,314,323,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
FN(N-Glycosylation)GSVSFFR{Hex:5; HexNAc:2},2275.943463437874,-2.9974280792499317e-06,11.6885492001,64.1360436246,0,95348913.75,62.1771895753,62.5319833106,62.377416609351,2,2,85,94,sp|P55083|MFAP4_HUMAN Microfibril-associated glycoprotein 4 OS=Homo sapiens OX=9606 GN=MFAP4 PE=1 SV=2,Unmodified
N(N-Glycosylation)DTASYK{Hex:6; HexNAc:2},2175.824884109807,2.9178785798237217e-06,16.8683809209,35.8854691383,0,380881594.75,28.007458757,28.4438366598,28.210731640085,2,1,207,214,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
N(N-Glycosylation)LTKLK{Hex:9; HexNAc:4},2986.255540312398,-1.143536546738051e-06,15.0271046095,39.1217007722,0,462051951.0,42.4594669249,43.1790876931,42.744323741023,3,2,1023,1029,sp|P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens OX=9606 GN=MYH11 PE=1 SV=3,Unmodified
LYWISSGN(N-Glycosylation)HTINR{Hex:5; HexNAc:2},2776.225437618401,-6.519869491252277e-06,-4.10802637664,35.5978610485,0,16073403.0,53.2671772744,53.357933059,53.357933058961,3,1,1755,1768,sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2,Unmodified
AIAAKHN(N-Glycosylation)KTTAQVLIR{Fuc:1; Hex:8; HexNAc:4},3989.85701137,-0.00025880343119,0,11.43267297,0.00662251655629,0,,,,3,2,235,251,sp|P15121|ALDR_HUMAN Aldo-keto reductase family 1 member B1 OS=Homo sapiens OX=9606 GN=AKR1B1 PE=1 SV=3,
FGFNPLEFEN(N-Glycosylation)FSWR{Fuc:1; Hex:8; HexNAc:8},4855.954436817033,-2.6678989725132532e-06,11.7284869668,23.1018413082,0,66670000,69.4206938412,69.7296247747,69.605644725386,4,1,890,904,sp|O15230|LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens OX=9606 GN=LAMA5 PE=1 SV=8,Unmodified
ILQDKLN(N-Glycosylation)STM(Oxidation)K{Fuc:1; Hex:5; HexNAc:5},3277.4034606178725,3.5593024378502324e-06,18.2889531033,51.6493787798,0,440978937.5,25.5325368272,25.7374480075,25.605751759434,3;4,2,2623,2634,"sp|Q14573|ITPR3_HUMAN Inositol 1,4,5-trisphosphate receptor type 3 OS=Homo sapiens OX=9606 GN=ITPR3 PE=1 SV=2",Unmodified
QRYHGFLN(N-Glycosylation)TSYHR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3883.63877941,-8.63035776855e-06,0,11.6812186316,0.00662251655629,0,,,,3,1,84,97,sp|P11117|PPAL_HUMAN Lysosomal acid phosphatase OS=Homo sapiens OX=9606 GN=ACP2 PE=1 SV=3,
TVDKKN(N-Glycosylation)ISEK{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3058.3464000240742,-7.909151554602115e-06,10.3235855276,47.6142442445,0,38472580.625,41.484856775,41.7393234239,41.575058407211,3,2,1293,1303,sp|Q14966|ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638 PE=1 SV=2,Unmodified
ALVN(N-Glycosylation)FTR{Hex:7; HexNAc:5; Neu5Ac:2},3551.4266349322615,-2.5027090562266364e-06,11.1024372722,45.757072723,0,342531280.5,67.3574556099,68.3282481418,67.905799240494,3,5,85,92,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,Unmodified
N(N-Glycosylation)MTLFSDLVAEK{Hex:7; HexNAc:6},3719.52929179,-8.17345860678e-07,0,10.6626295539,0.00662251655629,0,,,,3,1,784,796,sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,
N(N-Glycosylation)M(Oxidation)TLFSDLVAEK{Fuc:3; Hex:5; HexNAc:4},3443.41221442,5.31064763424e-06,0,7.669407908,0.0444444444444,0,,,,3,1,784,796,sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,
TAN(N-Glycosylation)DTSTEAYNLLLR{Hex:5; HexNAc:2},2897.2709429624115,-5.592258014879882e-06,13.1202938417,79.4533375191,0,213449812.5,67.3421255257,67.6884026236,67.530300242329,2;3,3,1202,1217,sp|P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3,Unmodified
LLNN(N-Glycosylation)LTSIK{Fuc:3; Hex:5; HexNAc:4},3075.35684272,1.89773387244e-06,0,19.2870934825,0,0,,,,3,1,646,655,sp|P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3,
LN(N-Glycosylation)DTVGVTK{Hex:5; HexNAc:2},2161.947560586957,-5.359904411395635e-06,16.0414261577,100.099145381,0,120177786.375,30.976363141,31.2390538401,31.079301793003,2,2,2749,2758,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
GSTRFN(N-Glycosylation)K{Hex:5; HexNAc:2},2024.8268590579496,7.483969398414276e-06,16.8313263903,11.3710845527,0,365715382.25,29.0505772259,29.5309097912,29.26898312432,2,2,2939,2946,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
IKN(N-Glycosylation)GTPPMRK{Fuc:2; Hex:4; HexNAc:5; Neu5Ac:1},3387.4753185639006,-3.5956674559407338e-06,-4.35084840186,10.615764468,0.00662251655629,15848127.25,65.3779680755,65.5169529901,65.377968075498,3,1,503,513,sp|O75533|SF3B1_HUMAN Splicing factor 3B subunit 1 OS=Homo sapiens OX=9606 GN=SF3B1 PE=1 SV=3,Unmodified
VN(N-Glycosylation)KTSK{Fuc:1; Hex:8; HexNAc:8},3742.503765882712,8.68231275513399e-07,12.3031135352,63.3177105379,0,306965350.0,42.6111190584,43.2541430261,42.774151876195,3;4;5,3,1053,1059,sp|Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1,Unmodified
VN(N-Glycosylation)KTSK{Fuc:4; Hex:6; HexNAc:6; Neu5Ac:1},3741.5005407670346,3.0002673106489578e-06,-4.6531936685,35.8855621897,0,31519329,42.714521208,42.923277341,42.744323741023,3;4;5,1,1053,1059,sp|Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1,Unmodified
N(N-Glycosylation)LSYQVHR{Fuc:1; Hex:7; HexNAc:6; Neu5Ac:1},3805.539751944683,-5.386950324773486e-06,10.5904558125,75.8532603378,0,337791401.75,71.7522682772,72.4197878903,72.186631793404,3;4,4,584,592,sp|O60716|CTND1_HUMAN Catenin delta-1 OS=Homo sapiens OX=9606 GN=CTNND1 PE=1 SV=1,Unmodified
LEIC(Carbamidomethyl)N(N-Glycosylation)LTPDALK{Fuc:3; Hex:5; HexNAc:4},3446.50051054,-6.5936234219e-06,0,20.8571081217,0,0,,,,3,1,347,359,sp|P07384|CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN1 PE=1 SV=1,
DRN(N-Glycosylation)NTEVER{Hex:9; HexNAc:5},3605.3743369389053,6.8785144555735115e-06,13.2545507374,41.1463298056,0,148359797.0,59.6025385406,60.0352859245,59.836350991948,3,3,1599,1608,sp|Q63HN8|RN213_HUMAN E3 ubiquitin-protein ligase RNF213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=3,Unmodified
KDRN(N-Glycosylation)NTEVER{Fuc:2; Hex:9; HexNAc:4},3823.56321325,-0.000270080169027,0,13.5176519221,0,0,,,,3,1,1598,1608,sp|Q63HN8|RN213_HUMAN E3 ubiquitin-protein ligase RNF213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=3,
LRSGN(N-Glycosylation)ASTM(Oxidation)TRR{Fuc:2; Hex:7; HexNAc:5},3806.5424153770377,9.013188491869677e-06,8.56791625549,26.3655249846,0,41584180.625,71.7063764439,72.3581037428,72.217512109502,3;4,1,846,858,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,Unmodified
ATAIN(N-Glycosylation)ASRALK{Fuc:1; Hex:7; HexNAc:3},3004.33134141,-6.5555323405e-06,0,7.65794423241,0.0444444444444,0,,,,2,1,1973,1984,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,
FVRLRN(N-Glycosylation)K{Hex:9; HexNAc:4},3202.389180482701,-7.716316668072195e-06,15.2322356988,39.0810218963,0,74365319.5,58.3939982242,58.6134845084,58.487526192888,3,2,450,457,sp|P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1,Unmodified
TALIN(N-Glycosylation)STGEEVAMR{Fuc:1; Hex:9; HexNAc:4},3908.6230603,-0.000264123171916,0,11.9470447827,0.00662251655629,0,,,,3,1,527,541,sp|P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1,
HSTEN(N-Glycosylation)DSPTNVQQ{Hex:8; HexNAc:5},3767.4285812092003,3.578777951377739e-06,8.99073338084,13.1090892151,0,29465205.25,59.5086676584,59.7438775923,59.555043676122,3,2,366,379,sp|P49354|FNTA_HUMAN Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha OS=Homo sapiens OX=9606 GN=FNTA PE=1 SV=1,Unmodified
EN(N-Glycosylation)LSAKR{Hex:8; HexNAc:4},2925.180545816667,1.674093553000756e-06,14.0169243348,74.7241526952,0,85134527.75,39.0261015084,39.3899014261,39.207597143078,3,2,617,624,sp|Q9UBT2|SAE2_HUMAN SUMO-activating enzyme subunit 2 OS=Homo sapiens OX=9606 GN=UBA2 PE=1 SV=2,Unmodified
AWN(N-Glycosylation)ESDLDVAYEK{Hex:8; HexNAc:3},3445.37996419,-0.000299054555727,0,8.75435079693,0.0231213872832,0,,,,3,1,248,261,sp|Q8WUF5|IASPP_HUMAN RelA-associated inhibitor OS=Homo sapiens OX=9606 GN=PPP1R13L PE=1 SV=4,
DVLN(N-Glycosylation)DTAPR{Fuc:1; Hex:6; HexNAc:8; Neu5Ac:1},4033.6040681841127,-7.413306509261337e-08,2.65536416205,75.2125074249,0,47005679.5,45.9383084085,46.2098387069,45.99966002566,4,1,558,567,sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,Unmodified
LVFN(N-Glycosylation)RTVTLK{Fuc:1; Hex:8; HexNAc:4},3444.5064466351487,2.85451122638985e-06,12.8135805159,16.1382351996,0,114547627.0,80.6832254078,80.93300286,80.808084609731,3,3,759,769,sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,Unmodified
VKAEGPGLN(N-Glycosylation)R{Hex:7; HexNAc:6; Neu5Ac:1},3683.51559778,8.85020975991e-07,0,17.6610732886,0,0,,,,3,1,869,879,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,
LTIGSN(N-Glycosylation)LSIR{Hex:5; HexNAc:3; Neu5Ac:1},2783.2166577003377,1.8149904457758336e-06,-4.28204277515,11.0750475504,0.00662251655629,6881931.375,83.9621809588,84.0417267905,83.993694375579,3,1,250,260,sp|P13010|XRCC5_HUMAN X-ray repair cross-complementing protein 5 OS=Homo sapiens OX=9606 GN=XRCC5 PE=1 SV=3,Unmodified
ISESLRTVN(N-Glycosylation)MTWNK{Hex:5; HexNAc:4; Neu5Ac:2},3882.635006262579,-3.020091270480991e-06,14.5667840924,26.2002494759,0,1362769709.25,82.7466379073,84.1359226094,83.393483093007,3,6,2159,2173,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,Unmodified
SNIVTVGDVEEIN(N-Glycosylation)K{Fuc:2; Hex:6; HexNAc:4},3592.566751296147,-1.0702944624005765e-05,9.17151476441,16.2216237258,0,11732858.75,68.1870330439,68.2817381249,68.233980876827,5,2,2250,2264,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,Unmodified
IIQRN(N-Glycosylation)R{Fuc:3; Hex:6; HexNAc:6},3427.44658888,7.97321475018e-07,0,69.8027437215,0,0,,,,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",
IIQRN(N-Glycosylation)R{Fuc:2; Hex:7; HexNAc:6},3443.467009101795,-6.613342226112689e-06,10.8519807093,69.6938706801,0,123452651.0,80.9491386599,81.3274477269,81.02844616038,3,3,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)RTER{Fuc:1; Hex:8; HexNAc:4},3439.4570399969357,4.288013902430194e-06,11.8412382751,59.9335710408,0,38162570.25,25.5472543742,25.6349454588,25.591251777236,4,1,582,591,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)RTER{Fuc:1; Hex:7; HexNAc:5},3480.48174012655,4.768710839269387e-06,15.4598663232,59.9055551174,0,93401336.0,25.722564676,25.8251167403,25.767463774109,3;4,2,582,591,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)R{Hex:6; HexNAc:6; Neu5Ac:1},3280.37868076,-2.33783789199e-06,0,42.5178213218,0,0,,,,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",
N(N-Glycosylation)RTERLSDLLDWK{Fuc:1; Hex:3; HexNAc:7},3698.636623373928,-1.6948427099573502e-06,13.9715936517,10.1685160443,0.0118343195266,230865207.75,46.1063366439,46.3302990582,46.224351643149,3;4,3,586,599,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
KN(N-Glycosylation)LTLSK{Fuc:1; Hex:6; HexNAc:6},3139.347473338542,-1.6359870341894574e-06,13.4114775158,59.2442524936,0,106029497.0,28.9912272241,29.2400697257,29.050577225908,3,2,924,931,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,Unmodified
KN(N-Glycosylation)LSYAPGYR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},3024.26669323,-2.47210677449e-06,0,13.303738108,0,0,,,,3,1,487,497,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,
TKPPLDHN(N-Glycosylation)ASATDYK{Hex:5; HexNAc:4; Neu5Ac:2},3861.58326865,-2.05328654685e-08,0,26.4211008913,0,0,,,,3,1,895,910,sp|O95425|SVIL_HUMAN Supervillin OS=Homo sapiens OX=9606 GN=SVIL PE=1 SV=2,
TKPPLDHN(N-Glycosylation)ASATDYK{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3862.58370253,5.14886500086e-06,0,16.1794142035,0,0,,,,3,1,895,910,sp|O95425|SVIL_HUMAN Supervillin OS=Homo sapiens OX=9606 GN=SVIL PE=1 SV=2,
MKQLAN(N-Glycosylation)QTVGR{Fuc:2; Hex:6; HexNAc:4; Neu5Ac:2},3903.59134753,4.01517950376e-06,0,10.0072498439,0.0118343195266,0,,,,3,1,7,18,sp|Q68EM7|RHG17_HUMAN Rho GTPase-activating protein 17 OS=Homo sapiens OX=9606 GN=ARHGAP17 PE=1 SV=1,
LPTSALVN(N-Glycosylation)LSHGSR{Fuc:3; Hex:5; HexNAc:5; Neu5Ac:1},4005.73034521,-2.74524962557e-06,0,11.1372157307,0.00662251655629,0,,,,3,2,1163,1177,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,
TQEKVN(N-Glycosylation)ATGPQFVSGVIVK{Fuc:2; Hex:6; HexNAc:5},4280.95201757,-7.68676152276e-06,0,21.7924821124,0,0,,,,4,1,439,458,sp|Q4G0J3|LARP7_HUMAN La-related protein 7 OS=Homo sapiens OX=9606 GN=LARP7 PE=1 SV=1,
HARWFEEN(N-Glycosylation)ASQSTVK{Fuc:1; Hex:8; HexNAc:8; Neu5Ac:1},5147.05070609,2.82337239694e-06,0,15.7821786989,0,0,,,,4,1,206,221,sp|Q12905|ILF2_HUMAN Interleukin enhancer-binding factor 2 OS=Homo sapiens OX=9606 GN=ILF2 PE=1 SV=2,
LILDN(N-Glycosylation)DTIK{Fuc:1; Hex:8; HexNAc:7},3907.6195698475644,7.189797586990367e-07,12.2802781103,39.7647288096,0,111157197.5,70.9813678092,71.3276809758,71.139151126766,3,2,405,414,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,Unmodified
VREIRYQGGN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:4},3115.3505346252805,1.8331795526218226e-06,18.1091685074,67.9651868346,0,742146765.5,25.5912517772,25.8251167403,25.679363793755,3;4,4,1564,1575,sp|P04275|VWF_HUMAN von Willebrand factor OS=Homo sapiens OX=9606 GN=VWF PE=1 SV=4,Unmodified
EN(N-Glycosylation)LSPK{Hex:7; HexNAc:5},2836.1243549211868,7.67266399859434e-07,13.3805371122,62.3874378949,0,266136461.0,27.2533214238,27.6582996911,27.382724824174,3,2,431,437,sp|A0FGR8|ESYT2_HUMAN Extended synaptotagmin-2 OS=Homo sapiens OX=9606 GN=ESYT2 PE=1 SV=1,Unmodified
EN(N-Glycosylation)LSPK{Hex:8; HexNAc:5},2998.1798356066943,-1.6049873960883857e-07,14.8574104327,62.2960166577,0,151305569.0,27.1656914578,27.4411080585,27.253321423753,3,1,431,437,sp|A0FGR8|ESYT2_HUMAN Extended synaptotagmin-2 OS=Homo sapiens OX=9606 GN=ESYT2 PE=1 SV=1,Unmodified
LN(N-Glycosylation)DSHKHKDK{Fuc:1; Hex:7; HexNAc:6},3719.5404742,-2.79148498652e-06,0,9.22125543031,0.0118343195266,0,,,,3,1,17,27,sp|P11387|TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2,
ERGRN(N-Glycosylation)WSR{Hex:6; HexNAc:2},2438.007518506209,1.6013163125748958e-07,11.2239669316,75.6946233098,0,16625527.25,61.9152792082,62.1007808076,62.054116207981,2,1,2117,2125,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
FEGRLTKN(N-Glycosylation)M(Oxidation)SGSLYEM(Oxidation)VSR{Fuc:1; Hex:9; HexNAc:5; Neu5Ac:1},5147.04480005,8.24497188166e-06,0,18.4641213418,0,0,,,,4,1,297,316,sp|Q08945|SSRP1_HUMAN FACT complex subunit SSRP1 OS=Homo sapiens OX=9606 GN=SSRP1 PE=1 SV=1,
LDHFNFERFGN(N-Glycosylation)K{Hex:6; HexNAc:2},2901.219899490542,-4.309542349490002e-06,13.5903050654,12.5522866515,0,43794756.5,38.9202786909,39.0865114238,38.994814891243,3,2,39,51,sp|Q9UHL4|DPP2_HUMAN Dipeptidyl peptidase 2 OS=Homo sapiens OX=9606 GN=DPP7 PE=1 SV=3,Unmodified
KEALKEN(N-Glycosylation)K{Hex:5; HexNAc:4; Neu5Ac:2},3163.3122201689594,1.5695950303592148e-06,12.8997962358,35.3187728054,0,391180236.0,40.152135792,41.1395440922,40.540587606653,3,2,1492,1500,sp|Q14789|GOGB1_HUMAN Golgin subfamily B member 1 OS=Homo sapiens OX=9606 GN=GOLGB1 PE=1 SV=2,Unmodified
LTFDEYRN(N-Glycosylation)ISQK{Hex:5; HexNAc:4},3135.3454943200377,-2.1146305916531972e-06,13.3967909187,13.50443614,0,80991756.0,75.8723508583,76.1264721738,76.014534209792,3,1,210,222,sp|P12429|ANXA3_HUMAN Annexin A3 OS=Homo sapiens OX=9606 GN=ANXA3 PE=1 SV=3,Unmodified
WEIRN(N-Glycosylation)ISGR{Hex:5; HexNAc:2},2346.02952039,-3.16192354151e-06,0,19.1870458061,0,0,,,,2,1,1082,1091,sp|Q9NY15|STAB1_HUMAN Stabilin-1 OS=Homo sapiens OX=9606 GN=STAB1 PE=1 SV=3,
DGKN(N-Glycosylation)ATTDALTSVLTKINR{Fuc:3; Hex:5; HexNAc:5},4280.93935222,-5.66792783156e-06,0,14.8462539045,0,0,,,,3,1,4144,4163,sp|Q12955|ANK3_HUMAN Ankyrin-3 OS=Homo sapiens OX=9606 GN=ANK3 PE=1 SV=3,
N(N-Glycosylation)ITRELK{Fuc:1; Hex:6; HexNAc:4; Neu5Ac:1},3094.3031899826055,-2.4136015822930654e-06,16.0671332663,19.1065357252,0,479213566.75,38.2221481071,38.9647149072,38.548977790896,3,2,1658,1665,sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4,Unmodified
TSQEDFN(N-Glycosylation)KTELEK{Fuc:1; Hex:8; HexNAc:4},3823.55425819,-0.000266686626836,0,10.8122420978,0.00662251655629,0,,,,3,1,1541,1554,sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4,
DNSRGRDLN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:4},3116.27095561,5.66829566213e-06,0,8.97146325027,0.0176470588235,0,,,,3,1,208,218,sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2,
N(N-Glycosylation)LTFNITKTIR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},3873.6916045052803,-6.6469282507759885e-06,11.5655139828,40.3608366351,0,155763171.25,49.2083355413,49.4936218089,49.343756241226,3;4,2,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
NLTFN(N-Glycosylation)ITKTIR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},3873.6916045052803,-6.6469282507759885e-06,11.5655139828,40.3608366351,0,155763171.25,49.2083355413,49.4936218089,49.343756241226,3;4,2,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
LSPFN(N-Glycosylation)ITHR{Hex:8; HexNAc:3},2990.27299569,-0.000344370962108,0,21.9839938795,0,0,,,,3,1,569,578,"sp|Q92835|SHIP1_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",
KLSPFN(N-Glycosylation)ITHR{Fuc:1; Hex:5; HexNAc:5},3183.4099460827156,-4.261777240568508e-06,-4.0215044975,16.4253039705,0,18895306.75,76.8521527436,76.963289327,76.963289327049,3,1,568,578,"sp|Q92835|SHIP1_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",Unmodified
MVPC(Carbamidomethyl)WNHGN(N-Glycosylation)ITR{Hex:5; HexNAc:4; Neu5Ac:1},3397.37170972,-3.94805758289e-06,0,10.4590714272,0.00662251655629,0,,,,3,1,0,12,"sp|Q92835|SHIP1_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",
SLEN(N-Glycosylation)ITALRK{Hex:7; HexNAc:4; Neu5Ac:2},3672.5411290947486,-5.092482324287429e-07,15.8857782725,16.7055830524,0,378350246.75,39.4195201741,40.2105769938,39.779874991004,3,2,1165,1175,sp|Q5RHP9|ERIC3_HUMAN Glutamate-rich protein 3 OS=Homo sapiens OX=9606 GN=ERICH3 PE=1 SV=1,Unmodified
ITREN(N-Glycosylation)R{Fuc:1; Hex:8; HexNAc:5; Neu5Ac:2},3827.516782743967,-4.844206319612802e-06,10.9378587364,10.1486970617,0.00662251655629,20687980.375,23.2080355909,23.4543143418,23.362972210471,4;5,2,243,249,sp|Q5RHP9|ERIC3_HUMAN Glutamate-rich protein 3 OS=Homo sapiens OX=9606 GN=ERICH3 PE=1 SV=1,Unmodified
RGWLTINN(N-Glycosylation)ISLM(Oxidation)K{Fuc:3; Hex:6; HexNAc:5},3986.74673878,-3.65619064242e-06,0,10.5996687328,0.00662251655629,0,,,,3,2,522,535,sp|P50570|DYN2_HUMAN Dynamin-2 OS=Homo sapiens OX=9606 GN=DNM2 PE=1 SV=2,
IDN(N-Glycosylation)ETQKISQLAAVNR{Hex:8; HexNAc:2},3502.55360812,-0.000290802321452,0,9.57117275234,0.0118343195266,0,,,,3,1,616,632,sp|P29590|PML_HUMAN Protein PML OS=Homo sapiens OX=9606 GN=PML PE=1 SV=3,
LINDYVKN(N-Glycosylation)GTR{Fuc:2; Hex:6; HexNAc:5; Neu5Ac:1},3862.60440583,2.3509006995e-06,0,16.5213904079,0,0,,,,3,1,178,189,sp|P01011|AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens OX=9606 GN=SERPINA3 PE=1 SV=2,
VTAVDVSTN(N-Glycosylation)RSVR{Fuc:1; Hex:9; HexNAc:5; Neu5Ac:2},4604.858599147882,3.313110624071586e-06,10.040100119,19.7686390811,0,301632362.0,86.2535230742,86.8550707088,86.522774623458,3;4,1,665,678,sp|Q96MM6|HS12B_HUMAN Heat shock 70 kDa protein 12B OS=Homo sapiens OX=9606 GN=HSPA12B PE=1 SV=2,Unmodified
QN(N-Glycosylation)NTFPFFSEGITR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3862.58254927,-2.28306735299e-08,0,19.0351455551,0,0,,,,3,1,286,300,sp|Q9BYX2|TBD2A_HUMAN TBC1 domain family member 2A OS=Homo sapiens OX=9606 GN=TBC1D2 PE=1 SV=3,
QIELDLN(N-Glycosylation)R{Hex:8; HexNAc:4; Neu5Ac:2},3690.4609730296206,1.3131438876296216e-06,11.9294869681,13.6731733935,0,31435843.5,23.6362735099,23.8174801098,23.712543359025,3;4,2,668,676,sp|Q9BYX2|TBD2A_HUMAN TBC1 domain family member 2A OS=Homo sapiens OX=9606 GN=TBC1D2 PE=1 SV=3,Unmodified
N(N-Glycosylation)C(Carbamidomethyl)TSFRAR{Hex:6; HexNAc:4},2795.102096132961,1.4067404600250864e-06,17.1749963331,59.4977136945,0,874312716.0,26.9226223097,27.3827248242,27.066163490836,2;3,4,633,641,sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2,Unmodified
KNQEN(N-Glycosylation)ISSVK{Fuc:3; Hex:6; HexNAc:5; Neu5Ac:1},3862.5867202,7.16354244601e-08,0,15.1264035598,0,0,,,,3,1,739,749,sp|O76041|NEBL_HUMAN Nebulette OS=Homo sapiens OX=9606 GN=NEBL PE=1 SV=1,
GKTILISAHGN(N-Glycosylation)SSR{Fuc:1; Hex:8; HexNAc:4},3695.62086202,-0.000280981457279,0,9.50567886877,0.0118343195266,0,,,,3,1,179,193,sp|P07738|PMGE_HUMAN Bisphosphoglycerate mutase OS=Homo sapiens OX=9606 GN=BPGM PE=1 SV=2,
N(N-Glycosylation)DSLRK{Fuc:1; Hex:4; HexNAc:3},2134.890497335996,4.414401186250815e-06,14.1563115666,35.2342002656,0,182438176,26.2136911935,26.3990194267,26.313367325687,2,2,187,193,sp|Q15631|TSN_HUMAN Translin OS=Homo sapiens OX=9606 GN=TSN PE=1 SV=1,Unmodified
RGFFNLN(N-Glycosylation)R{Fuc:2; Hex:4; HexNAc:4},2775.2059423113665,-7.330563932760079e-06,7.97710251265,10.1869464162,0.010752688172,17214012.75,53.1740055587,53.4195047762,53.388177675629,3,1,42,50,sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,Unmodified
QLALLLWKN(N-Glycosylation)YTLQKR{Fuc:1; Hex:4; HexNAc:4},3493.703024115315,-1.9731946613359502e-06,-21.6707822619,7.81343183148,0.0444444444444,2751242.75,77.5454080409,77.5454080409,77.545408040905,3,1,5,20,sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2,Unmodified
VTRDDAGN(N-Glycosylation)YTC(Carbamidomethyl)IASNGPQGQIR{Fuc:1; Hex:9; HexNAc:5; Neu5Ac:1},5303.152798034522,-1.5518293355587823e-06,11.6865944668,12.6219488503,0,60520525.5,68.3604919738,68.6243058072,68.499857460086,4;5,1,559,581,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,Unmodified
FKLPKFN(N-Glycosylation)FSGSK{Fuc:1; Hex:8; HexNAc:4},3654.59261815,-0.000281470678483,0,9.73153717087,0.0118343195266,0,,,,3,1,3351,3363,sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2,
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3968.7041015712057,-3.7922101600012323e-06,11.9333123253,24.6774413424,0,156134072.0,88.6100462264,89.3550677087,88.864292008305,3,4,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3677.60573877609,-3.2912368073897077e-06,12.5958693092,23.7709758303,0,47555449.25,82.7946015106,83.0635965572,82.921522190793,3,3,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3969.706930365315,6.353459659871676e-07,-21.5597335732,14.677125462,0,2890328.5,89.3708813733,89.3708813733,89.37088137331,3,4,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
VKDLMVIN(N-Glycosylation)R{Hex:5; HexNAc:7},3318.426010540313,4.7203307251478055e-06,13.6061088003,68.6516126659,0,139762660.75,25.7525798585,25.8840146568,25.839249140644,3;4,4,221,230,sp|Q96KA5|CLP1L_HUMAN Lipid scramblase CLPTM1L OS=Homo sapiens OX=9606 GN=CLPTM1L PE=1 SV=1,Unmodified
YN(N-Glycosylation)ESLKC(Carbamidomethyl)ER{Fuc:1; Hex:5; HexNAc:4},2966.208167828405,-8.033765850659344e-06,11.4236339185,67.6440489098,0,28892189.0,39.4492451932,39.7184451248,39.553943060462,3,2,1033,1042,sp|Q8IZS8|CA2D3_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Homo sapiens OX=9606 GN=CACNA2D3 PE=1 SV=1,Unmodified
N(N-Glycosylation)LTFEGPLPEK{Fuc:2; Hex:7; HexNAc:5},3685.5524749194938,-6.831465845336911e-06,9.89180937278,15.0941787401,0,21564119.0,77.5454080409,77.7982784258,77.545408040905,3,3,400,411,sp|Q9HAT2|SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens OX=9606 GN=SIAE PE=1 SV=1,Unmodified
VSN(N-Glycosylation)YSR{Hex:6; HexNAc:4; Neu5Ac:2},3091.1917894030507,-5.215916594431264e-06,14.7073051703,46.8230567848,0,310280376.75,25.6936975585,26.142422476,25.82511674029,3,2,198,204,sp|P15328|FOLR1_HUMAN Folate receptor alpha OS=Homo sapiens OX=9606 GN=FOLR1 PE=1 SV=3,Unmodified
KN(N-Glycosylation)ITYEELR{Fuc:3; Hex:6; HexNAc:8},4199.72211148,4.14857872667e-06,0,11.3946418248,0,0,,,,3,1,194,203,sp|Q9NX40|OCAD1_HUMAN OCIA domain-containing protein 1 OS=Homo sapiens OX=9606 GN=OCIAD1 PE=1 SV=1,
ADLVN(N-Glycosylation)R{Fuc:2; Hex:6; HexNAc:4},2763.1220134628347,-2.2707242467798009e-07,11.3988875283,93.3475774923,0,679241059.0,39.1315105425,39.9589779085,39.718445124849,2;3,6,374,380,sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,Unmodified
ADLVN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:5},2804.149328733995,-4.969774438180439e-07,13.7994505301,69.9567933304,0,171131600.75,39.809540024,40.225508307,39.973924957339,3,2,374,380,sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,Unmodified
N(N-Glycosylation)NTVTPGGKPNKTR{Fuc:2; Hex:8; HexNAc:4},3883.65102694,-1.24712543875e-06,0,9.49343219802,0.0118343195266,0,,,,3,1,54,68,sp|P18077|RL35A_HUMAN Large ribosomal subunit protein eL33 OS=Homo sapiens OX=9606 GN=RPL35A PE=1 SV=2,
M(Oxidation)SSFN(N-Glycosylation)LSR{Fuc:2; Hex:7; HexNAc:5},3398.338766302815,-5.224909800444517e-06,-21.4729397486,8.21036936903,0.0208333333333,2513472.25,63.4617814408,63.4617814408,63.461781440798,3,3,2856,2864,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,Unmodified
N(N-Glycosylation)STLPKAIVSSR{Fuc:3; Hex:6; HexNAc:6},3900.67733983,2.3871596772e-06,0,8.1298842233,0.0342857142857,0,,,,3,1,1065,1077,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,
EDSN(N-Glycosylation)LTLQEK{Hex:4; HexNAc:2},2229.919582465348,7.82670309690515e-06,13.6426027376,17.856760151,0,272363275.5,49.4046622581,49.8279354241,49.632570893192,2,1,1445,1455,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,Unmodified
LIFQM(Oxidation)PQN(N-Glycosylation)KSTK{Fuc:1; Hex:8; HexNAc:5; Neu5Ac:1},4198.721646510264,3.8379314522951184e-06,-7.37109938843,10.8307458799,0.00662251655629,9854886.25,74.7695765243,75.0357968754,75.035796875381,3,1,988,1000,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,Unmodified
GLFWN(N-Glycosylation)GTLC(Carbamidomethyl)VPAAHC(Carbamidomethyl)PC(Carbamidomethyl)YYC(Carbamidomethyl)R{Fuc:1; Hex:8; HexNAc:4},4856.954232362787,-0.00021388898690574267,4.1615532031,10.5478119231,0.00662251655629,43178762.5,69.4824588921,69.6363792247,69.51288467509,4,1,510,531,sp|A2VEC9|SSPO_HUMAN SCO-spondin OS=Homo sapiens OX=9606 GN=SSPOP PE=2 SV=2,Unmodified
VLQDELEN(N-Glycosylation)R{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3012.252095102526,-2.7004128735423323e-06,14.0978599075,67.7862112769,0,262787509.5,38.2956303583,38.9948148912,38.578545974318,3,2,869,878,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,Unmodified
LKN(N-Glycosylation)ISPK{Hex:6; HexNAc:6},2989.2865888619394,9.785366017811284e-07,11.3440310579,10.1412328224,0.010752688172,43015692.0,76.3632183935,76.5680006927,76.45797200861,3,1,615,622,sp|Q8NDH2|CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=3,Unmodified
LEMQWN(N-Glycosylation)MTDK{Hex:4; HexNAc:2},2348.9291148373895,4.051996660896148e-06,14.1289508288,9.88321548129,0.0118343195266,211695187.25,28.5301647928,29.0357255922,28.717668826008,2,1,3598,3608,sp|Q8NDH2|CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=3,Unmodified
M(Oxidation)SLQLYLVDN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3717.5351406213167,-3.579056190164064e-06,7.59797005552,19.1838165018,0,32510361.25,88.2596300072,88.5936170604,88.387227891509,3,1,452,463,sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2,Unmodified
M(Oxidation)SLQLYLVDN(N-Glycosylation)R{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3718.53499018,1.94868836751e-06,0,18.7871684038,0,0,,,,3,1,452,463,sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2,
M(Oxidation)SLQLYLVDN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:4},3281.37692236,3.65358224706e-06,0,13.0987678003,0,0,,,,3,2,452,463,sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2,
VFAEN(N-Glycosylation)ETGLSRPR{Fuc:3; Hex:6; HexNAc:5},3900.66446974,-6.17839770824e-06,0,12.950354165,0,0,,,,3,1,31431,31444,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
KGN(N-Glycosylation)YSER{Fuc:3; Hex:5; HexNAc:5},3116.25749971,-4.43278998013e-06,0,9.40065305436,0.0208333333333,0,,,,3,1,36,43,sp|P20671|H2A1D_HUMAN Histone H2A type 1-D OS=Homo sapiens OX=9606 GN=H2AC7 PE=1 SV=2,
